Serotherapy of cancer.
Harris
D T
DT
Department of Medicine, Lankenau Hospital, Philadelphia, PA 19151.
Mastrangelo
M J
MJ
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000096:biosynthesis / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000008:administration & dosage / Q000276:immunology; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic; D005770:Gastrointestinal Neoplasms / Q000628:therapy; D006801:Humans; D007116:Immunization, Passive / Q000379:methods; D007167:Immunotherapy / Q000379:methods; D000922:Immunotoxins / Q000627:therapeutic use; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use; D007938:Leukemia / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D008545:Melanoma / Q000628:therapy; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D014118:Toxins, Biological / Q000008:administration & dosage / Q000627:therapeutic use; D014612:Vaccines / Q000276:immunology
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D000922:Immunotoxins; D007457:Iodine Radioisotopes; D014118:Toxins, Biological; D014612:Vaccines